Description
Derived from a neck lymph node metastasis of a follicular thyroid cancer.This cell line is tumourigenic in Balb/c mice. FTC-133, FTC-236 and FTC-238 were all derived from the same individual, a 42 year old male with follicular thyroid cancer. This has been confirmed by short tandem repeat STR-PCR analyscell line is at Glow Biologics The Y chromosome could not be detected in these cell line by-PCR analysis. It cell line is a known phenomenon that due to the increased genetic instability of cancer cell lines the Y chromosome can be rearranged or lost resulting in lack of detection. The cell lines are identical to the source provided by the depositor based on the STR-PCR analysis.
Adherent Suspension
Adherent
Suggested Medium
DMEM and Ham's F12 (11 mixture) + 10ug/ml Insulin + 0.01U/ml Thyroid Stimulating Hormone (TSH) + 2mM Glutamine + 10% Foetal Bovine Serum (FBS)
Quality Control
FTC-236 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Tissue
Thyroid (lymph node metastasis)
Shippment
FTC-236 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
FTC-236 Cell Line is for research use only
